CB Scientific, Inc. (CBSC)
USD 0.04
(-11.11%)
USD 0.04
(-11.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.59 Million USD | 24.08% |
| 2022 | -2.1 Million USD | -12.35% |
| 2021 | -1.87 Million USD | 36.42% |
| 2020 | -2.94 Million USD | -194.42% |
| 2019 | -999.45 Thousand USD | -1497.33% |
| 2018 | -62.57 Thousand USD | 87.0% |
| 2017 | -481.39 Thousand USD | -30.19% |
| 2016 | -369.76 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -264.06 Thousand USD | 20.34% |
| 2023 Q4 | -331.48 Thousand USD | 31.6% |
| 2023 Q3 | -484.64 Thousand USD | -5.2% |
| 2023 Q1 | -318.88 Thousand USD | 61.03% |
| 2023 Q2 | -460.69 Thousand USD | -44.47% |
| 2023 FY | -1.59 Million USD | 24.08% |
| 2022 Q2 | -420.64 Thousand USD | 4.37% |
| 2022 FY | -2.1 Million USD | -12.35% |
| 2022 Q4 | -818.21 Thousand USD | -93.35% |
| 2022 Q3 | -423.18 Thousand USD | -0.6% |
| 2022 Q1 | -439.87 Thousand USD | 55.44% |
| 2021 Q3 | -481.13 Thousand USD | -161.32% |
| 2021 Q1 | -218.36 Thousand USD | 88.09% |
| 2021 Q2 | -184.11 Thousand USD | 15.68% |
| 2021 Q4 | -987.21 Thousand USD | -105.19% |
| 2021 FY | -1.87 Million USD | 36.42% |
| 2020 FY | -2.94 Million USD | -194.42% |
| 2020 Q4 | -1.83 Million USD | 0.0% |
| 2019 FY | -999.45 Thousand USD | -1497.33% |
| 2018 FY | -62.57 Thousand USD | 87.0% |
| 2017 Q4 | -505.84 USD | 0.0% |
| 2017 FY | -481.39 Thousand USD | -30.19% |
| 2016 FY | -369.76 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 237.062% |
| Ansell Limited | 129.3 Million USD | 101.234% |
| Ansell Limited | 129.3 Million USD | 101.234% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 105.125% |
| BioLife Sciences Inc. | - USD | Infinity% |
| Psykey, Inc. | -797.5 Thousand USD | -100.087% |
| ConvaTec Group Plc | 262.7 Million USD | 100.607% |
| ConvaTec Group Plc | 262.7 Million USD | 100.607% |
| Encision Inc. | -640.78 Thousand USD | -149.024% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -1025.239% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -1351.561% |
| Innovative MedTech Inc. | -4.27 Million USD | 62.666% |
| LifePoint, Inc. | -7.49 Million USD | 78.71% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 75.375% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 583.546% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -1198.479% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | -241.489% |
| SmileDirectClub, Inc. | -241.15 Million USD | 99.338% |
| Sector 10, Inc. | -39.84 Thousand USD | -3904.871% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.499% |
| SheerVision, Inc. | 155.72 Thousand USD | 1124.685% |
| United Health Products, Inc. | -2.42 Million USD | 34.24% |
| Vasamed, Inc. | 4.74 Million USD | 133.648% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 30.445% |
| Yubo International Biotech Limited | -1.2 Million USD | -32.399% |